Caldolor® now fda approved for pre-operative administration

Nashville, tenn., nov. 29, 2021 /prnewswire/ -- cumberland pharmaceuticals inc. (nasdaq: cpix), a specialty pharmaceutical company today announced the u.s. food and drug administration (fda) has approved expanded labeling for caldolor®, an intravenously delivered formulation of ibuprofen, to now include use in pre-operative administration.
CPIX Ratings Summary
CPIX Quant Ranking